-transparent.png){kind=logo}
A previous study demonstrated that the translational inhibitor from lysates of heme-deficient rabbit reticulocytes is associated with a protein kinase activity. Chromatography of this inhibitor preparation on phosphocellulose yields two distinct protein kinase activities, PC1 and PC2. PC1, which consitutes about 90% of the activity in the unresolved preparation, does not inhibit protein synthesis in lysates, but actively phosporylates calf thymus histone II in a 3':5'-cyclic AMP-denpendent reaction. PC2 contains the translational inhibitor, phosphorylates histone poorly, and is not cyclic AMP-dependent. While [gamma-32P]ATP as the phosphate donor, the two kinase fractions were analyzed with the putative substrates, salt-washed 40S ribosomal subunits, and the initiation factor that mediates the binding of Met-tRNAf to the 40S subunit. PC1 is inactive with the initiation factor, but phosphorylates 40S subunits at a single major site that migrates as a 31,000-dalton band in sodium dodecyl sulfate-acrylamide gels; phosphorylation requires cyclic AMP. Similar phosphorylation of the reticulocyte 40S site (31,000 daltons) can be demonstrated with other cyclic AMP-dependent kinases from reticulocytes, rat liver, and bovine heart muscle. PC2 phosphorylates the small subunit (38,000 daltons) but not the large subunit(s) of the initiation factor; the reaction does not require cyclic AMP. PC2 does not phosphorylate 40S subunits. In the presence of 40S subunits, the initiation factor appears to be rapidly bound in a manner that effectively blocks phosphorylation of the initiation factor by PC2; under the same conditions phosphorylation of the 40S subunit by PC1 is not affected. The initiation factor has been shown to reverse the inhibitions of protein chain initiation induced in lysates by heme deficiency, double-stranded RNA, oxidized glutathione, or the purified translational inhibitor. The observation that the Met-tRNAf binding factor is phosphorylated by PC2 supports the hypothesis that this initiation factor is a target for the action of the translational inhibitor activated in heme deficiency.
D Levin, and
R S Ranu, and
V Ernst, and
I M London
March 1977,
Nature,
D Levin, and
R S Ranu, and
V Ernst, and
I M London
August 1978,
Proceedings of the National Academy of Sciences of the United States of America,
D Levin, and
R S Ranu, and
V Ernst, and
I M London
November 1989,
FEBS letters,
D Levin, and
R S Ranu, and
V Ernst, and
I M London
April 1982,
Proceedings of the National Academy of Sciences of the United States of America,
D Levin, and
R S Ranu, and
V Ernst, and
I M London
November 1986,
FEBS letters,
D Levin, and
R S Ranu, and
V Ernst, and
I M London
February 1994,
The Journal of biological chemistry,
D Levin, and
R S Ranu, and
V Ernst, and
I M London
January 1979,
Methods in enzymology,
D Levin, and
R S Ranu, and
V Ernst, and
I M London
December 1982,
Biochemical and biophysical research communications,
D Levin, and
R S Ranu, and
V Ernst, and
I M London
February 1979,
Biochemical and biophysical research communications,
D Levin, and
R S Ranu, and
V Ernst, and
I M London
November 1988,
Biochemical and biophysical research communications,
